Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Aus study boosts Biogen drug

Posted 4 May 2021 AM

Australian researchers have provided confidence for women with multiple sclerosis looking to conceive, revealing Biogen's Tysabri is an effective therapy during pregnancy in a new MS Research Australia funded study, published in Neurology.

In the past, women with MS were advised to stop taking any MS medications in order to conceive, putting patients at increased risk of their disease activity returning whilst trying to become pregnant.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended